Market Research Logo

Global Antibiotics Market 2017-2021

About Antibiotics

An antibiotic is a chemical compound that kills or slows down the growth of any disease-causing microorganisms such as bacteria, parasite, and fungi but is not effective against viruses and prions. The term antibiotic was originally coined to refer to any compound of microbial origin that is antagonistic to the growth of the microbe. Antibiotics act via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis.

Technavio’s analysts forecast the global antibiotics market to grow at a CAGR of 2.16% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global antibiotics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Antibiotics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Allergan
  • GlaxoSmithKline
  • Merck
  • Pfizer
Other prominent vendors
  • Abbott
  • Achaogen
  • Actelion Pharmaceuticals
  • AmpliPhi Biosciences
  • Aspen Pharmacare
  • Astellas Pharma
  • AstraZeneca
  • Aurobindo Pharma
  • Baxter
  • Basilea Pharmaceutica
  • Bayer HealthCare
  • Biocon
  • Bristol-Myers Squibb
  • Cempra
  • Cipher Pharmaceuticals
  • CordenPharma
  • Chiesi Farmaceutici
  • Eli Lilly
  • Exoxemis
  • F. Hoffmann-La Roche
  • Flynn Pharma
  • Incepta Pharmaceuticals
  • InSite Vision
  • Insmed
  • Johnson & Johnson
  • Humanigen
  • Kyorin Pharmaceutical
  • Lupin Pharmaceuticals
  • Lytix Biopharma
  • Melinta Therapeutics
  • Mylan
  • Nektar
  • Orchid Pharma
  • Par Pharmaceutical
  • Paratek Pharmaceuticals
  • Pernix Therapeutics
  • PTC Therapeutics
  • RedHill
  • Sagent Pharmaceuticals
  • Sanofi
  • Shionogi
  • Starpharma
  • Sun Pharmaceutical
  • Symbiomix
  • Takeda Pharmaceutical
  • Tetraphase Pharmaceuticals
  • Theravance Biopharma
  • The Medicines Company
  • Valneva
  • Wockhardt
Market driver
  • Rising prevalence of infectious diseases
  • For a full, detailed list, view our report
Market challenge
  • Development of antibiotic-resistant strains
  • For a full, detailed list, view our report
Market trend
  • Strategic alliances and mergers and acquisitions (M&A)
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Antibiotics Market 2017-2021

Technavio recognizes the following companies as the key players in the global antibiotics market: Allergan, GlaxoSmithKline, Merck, and Pfizer.

Other Prominent Vendors in the market are: Abbott, Achaogen, Actelion Pharmaceuticals, AmpliPhi Biosciences, Aspen Pharmacare, Astellas Pharma, AstraZeneca, Aurobindo Pharma, Baxter, Basilea Pharmaceutica, Bayer HealthCare, Biocon, Bristol-Myers Squibb, Cempra, Cipher Pharmaceuticals, CordenPharma, Chiesi Farmaceutici, Eli Lilly, Exoxemis, F. Hoffmann-La Roche, Flynn Pharma, Incepta Pharmaceuticals, InSite Vision, Insmed, Johnson & Johnson, Humanigen, Kyorin Pharmaceutical, Lupin Pharmaceuticals, Lytix Biopharma, Melinta Therapeutics, Mylan, Nektar, Orchid Pharma, Par Pharmaceutical, Paratek Pharmaceuticals, Pernix Therapeutics, PTC Therapeutics, RedHill, Sagent Pharmaceuticals, Sanofi, Shionogi, Starpharma, Sun Pharmaceutical, Symbiomix, Takeda Pharmaceutical, Tetraphase Pharmaceuticals, Theravance Biopharma, The Medicines Company, Valneva, and Wockhardt.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Strategic alliances and mergers and acquisitions (M&A). Formation of strategic alliances, in terms of licensing and collaboration, help in the co-development and commercialization of drugs in different regions. Co-development agreements between different companies enable the use of technical expertize from both companies. These agreements also allow the use of regulatory and development experience gained by one company for the support of pipeline candidates of another company.”

According to the report, one of the major drivers for this market is Rising prevalence of infectious diseases. Globally, there has been an increase in the number individuals affected by infectious diseases. Infectious diseases are caused by pathogens and can be transmitted from one person to another through direct or indirect contact. Thus, factors that favor the growth and transmission of these pathogens contribute to the spread of infectious diseases. Demographic changes caused by increased globalization and urbanization are a major factor leading to the global emergence of infectious diseases.

Further, the report states that one of the major factors hindering the growth of this market is Development of antibiotic-resistant strains. The development of multidrug-resistant microbes is one of the major threats to the human health in the present days. The microbe changes itself to protect against the antimicrobial agent used and thereby develops resistance to the drug. The antibiotic resistance usually develops due to the irrational use of these drugs.

Companies Mentioned

Allergan, GlaxoSmithKline, Merck, Pfizer, Abbott, Achaogen, Actelion Pharmaceuticals, AmpliPhi Biosciences, Aspen Pharmacare, Astellas Pharma, AstraZeneca, Aurobindo Pharma, Baxter, Basilea Pharmaceutica, Bayer HealthCare, Biocon, Bristol-Myers Squibb, Cempra, Cipher Pharmaceuticals, CordenPharma, Chiesi Farmaceutici, Eli Lilly, Exoxemis, F. Hoffmann-La Roche, Flynn Pharma, Incepta Pharmaceuticals, InSite Vision, Insmed, Johnson & Johnson, Humanigen, Kyorin Pharmaceutical, Lupin Pharmaceuticals, Lytix Biopharma, Melinta Therapeutics, Mylan, Nektar, Orchid Pharma, Par Pharmaceutical, Paratek Pharmaceuticals, Pernix Therapeutics, PTC Therapeutics, RedHill, Sagent Pharmaceuticals, Sanofi, Shionogi, Starpharma, Sun Pharmaceutical, Symbiomix, Takeda Pharmaceutical, Tetraphase Pharmaceuticals, Theravance Biopharma, The Medicines Company, Valneva, and Wockhardt.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
  • Antibiotics: An overview
    • Introduction
      • Table Overview of mechanism of action of antibiotics
    • Mechanism of action of antibiotics
      • Table Mechanism of action of antibiotics
    • General principles for the use of antibiotics
      • Table General principles involved in the use of antibiotics
    • Clinical use of antibiotics
      • Table Clinical use of antibiotics for treatment of various common infections
    • Epidemiology of infections
      • Table Types of HAIs 2016
    • Application of antibiotics
  • Veterinary drug approval process
    • Animal antibiotics
    • NADAs and supplements
    • ANADAs and supplements
    • CNADAs
  • Antibiotic resistance: An overview
    • Cause of antibiotic resistance
      • Table Causes of antibiotic resistance
      • Table Transfer of antibiotic-resistant strain
    • Development of antibiotic resistance
      • Table Development of antibiotic resistance
    • Spread of antibiotic resistance
      • Table Spread of antibiotic resistance
      • Table Antibiotic resistance scenario in the US
    • Initiatives to facilitate antibiotic development
      • Table Initiatives to facilitate antibiotic development
  • Market landscape
    • Market overview
      • Table Global antibiotics market snapshot
    • Market size and forecast
      • Table Global antibiotics market revenue 2016-2021 ($ millions)
      • Table Opportunity analysis of global antibiotics market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline landscape of global antibiotics market 2016
    • Table Key clinical trials
    • Gepotidacin
    • MK-3415A
    • Amikacin Inhale
    • Carbavance
    • Eravacycline
    • Plazomicin
    • Delafloxacin
    • Solithromycin
    • ARIKAYCE
    • Cadazolid
    • Ozenoxacin
  • Market segmentation by chemical class
    • Table Segmentation of global antibiotics market by chemical class 2016
    • Table Segmentation of global antibiotics market share by chemical class 2016
    • Beta-lactams
      • Table Cephalosporin segmentation by generation of drugs
    • Macrolides
    • Quinolones
    • Others
  • Market segmentation by drug origin
    • Table Segmentation Global antibiotics market by drug origin 2016
    • Natural
    • Semisynthetic
    • Synthetic
  • Market segmentation by mechanism of action
    • Table Segmentation of global antibiotics market by mechanism of action 2016
    • Bacteriostatic
    • Bactericidal
  • Market segmentation by application
    • Table Segmentation of global antibiotics market by application 2016
    • Antibiotics for human use
    • Antibiotics for veterinary use
  • Market segmentation by spectrum
    • Table Segmentation of global antibiotics market by spectrum 2016
    • Table Global antibiotics market share by spectrum 2016
    • Broad-spectrum antibiotics
      • Table Global broad-spectrum antibiotics market 2016-2021 ($ millions)
    • Narrow-spectrum antibiotics
      • Table Global narrow-spectrum antibiotics market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Segmentation of global antibiotics market share by geography 2016 and 2021
    • Table Segmentation of global antibiotics market revenue by geography 2016-2021
    • Table Segmentation of global antibiotics market share by geography 2016-2021 (%)
    • Market overview
      • Table Antibiotics market scenario in different regions
    • Antibiotics market in APAC
      • Table Market scenario in APAC
      • Table Antibiotics market in APAC 2016-2021 ($ millions)
    • Antibiotics market in Americas
      • Table Market scenario in Americas
      • Table Antibiotics market in Americas 2016-2021 ($ millions)
      • Table Legislation regulating antibiotic use in US
    • Antibiotics market in EMEA
      • Table Market scenario in EMEA
      • Table Antibiotics market in EMEA 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Antibiotic-resistant strains according to the period of development of resistance
      • Table Antibiotic drug approvals versus time interval
  • Market trends
    • Strategic alliances and mergers and acquisitions (M&A)
    • Patient assistance programs (PAPs)
    • Increased federal and institutional funding on antibiotic research
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global antibiotics market 2016
  • Key vendor analysis
    • Allergan
      • Table Allergan: Key highlights
      • Table Allergan: Strength assessment
      • Table Allergan: Strategy assessment
      • Table Allergan: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck: Strategy assessment
      • Table Merck: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlight
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report